Peter Trenkwalder Selected Research

Peter Trenkwalder Research Topics

10	Hypertension (High Blood Pressure) 10/2015 - 01/2000
7	Stroke (Strokes) 10/2015 - 01/2000
3	Cognitive Dysfunction 08/2005 - 01/2000
1	Embolic Stroke 10/2015
1	Weight Loss (Weight Reduction) 10/2015
1	Edema (Dropsy) 04/2009
1	Cough 07/2008
1	Isolated Systolic Hypertension 09/2004
1	Dementia (Dementias) 05/2003
1	Essential Hypertension 05/2003
1	Heart Failure 01/2000
1	Diabetes Mellitus 01/2000
1	Atherosclerosis 01/2000
1	Myocardial Infarction 01/2000
1	Lung Diseases (Lung Disease) 01/2000
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2000

6	Antihypertensive Agents (Antihypertensives)IBA 04/2009 - 01/2000
5	candesartanIBA 03/2006 - 05/2003
3	candesartan cilexetil (Amias)FDA Link 01/2002 - 01/2000
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2014 - 07/2008
2	DiureticsIBA 01/2004 - 01/2000
2	Valsartan (Vals)FDA Link 01/2004 - 05/2003
1	CholesterolIBA 10/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015
1	aliskiren FDA Link 04/2009
1	Amlodipine (Norvasc)FDA LinkGeneric 04/2009
1	Ramipril (Altace)FDA LinkGeneric 07/2008
1	Indapamide FDA LinkGeneric 09/2006
1	Perindopril FDA LinkGeneric 09/2006
1	Angiotensin IIIBA 09/2004
1	Angiotensin II Type 1 Receptor BlockersIBA 09/2004
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2004
1	Angiotensin Receptor AntagonistsIBA 01/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2000
1	CalciumIBA 01/2000
1	LipidsIBA 01/2000

8	Therapeutics 04/2009 - 01/2000
1	Secondary Prevention 10/2015